Latest Breaking News On - கலப்பு தொழில்நுட்பம் - Page 9 : comparemela.com

Generic Segment to Grow at Faster Pace during Forecast Period Peptide Therapeutics Market is expected to reach US$ 50,003.15 million by 2027 from US$ 24,878.55 million in 2019; it is estimated to grow at a CAGR of 9.2% from 2020 to 2027. The report highlights trends prevailing in the market, and the factors driving and hindering the market growth. The growth of the peptide therapeutics market is mainly attributed to the growing investments on peptide therapeutics and increasing prevalence of metabolic disorders and infectious diseases. However, operational limitations of peptides deter the market growth. On the basis of type, the peptide therapeutics market is segmented into innovative and generic. The innovative segment held a larger share of the market in 2019; however, the generic segment is expected to register a higher CAGR during the forecast period. Rising number of research collaborations amongst market players are estimated to offer favorable environment for growth of gen

United statesSouth africaSaudi arabiaSouth koreaPharma gmbAsia pacificEli lillyLaura woodNovo nordiskSynthesis technologyTeva pharmaceuticalOffice hours callBristol myers squibb companyTeva pharmaceutical industries ltdE st office hours callAmgen inc